Takeshi Sano
#154,060
Most Influential Person Now
Takeshi Sano's AcademicInfluence.com Rankings
Takeshi Sanomedical Degrees
Medical
#3000
World Rank
#3449
Historical Rank
Surgery
#250
World Rank
#305
Historical Rank
Takeshi Sanophilosophy Degrees
Philosophy
#8649
World Rank
#12065
Historical Rank
Logic
#5674
World Rank
#7091
Historical Rank
Download Badge
Medical Philosophy
Takeshi Sano's Degrees
- Doctorate Medicine University of Tokyo
- PhD Surgery University of Tokyo
Why Is Takeshi Sano Influential?
(Suggest an Edit or Addition)Takeshi Sano's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. (2008) (723)
- Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. (2004) (631)
- Gastric cancer: Asia and the world (2017) (580)
- Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer (2009) (432)
- Management of gastric cancer in Asia: resource-stratified guidelines. (2013) (404)
- Lymph node metastasis from early gastric cancer: endoscopic resection of tumour (1992) (379)
- Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. (2006) (372)
- Recurrence of early gastric cancer. Follow‐up of 1475 patients and review of the Japanese literature (1993) (331)
- Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project (2017) (321)
- Risk factors for lymph node metastasis from intramucosal gastric carcinoma (1996) (300)
- Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. (2012) (278)
- Gastric adenocarcinoma (2017) (258)
- New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points (2011) (236)
- Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma (2017) (230)
- Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database (2017) (219)
- Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer (2012) (212)
- Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial (2019) (207)
- Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer (2009) (198)
- Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer (2001) (193)
- Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer (2005) (186)
- Pancreas-preserving total gastrectomy for proximal gastric cancer (1995) (182)
- Early gastric cancer. Endoscopic diagnosis of depth of invasion. (1990) (164)
- Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer (2007) (159)
- Endoscopic evaluation of the remnant stomach after gastrectomy: proposal for a new classification (2002) (148)
- Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma (2017) (143)
- Influence of Overweight on Surgical Complications for Gastric Cancer: Results From a Randomized Control Trial Comparing D2 and Extended Para-aortic D3 Lymphadenectomy (JCOG9501) (2007) (133)
- Treatment strategy after non‐curative endoscopic resection of early gastric cancer (2008) (132)
- High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302 (2014) (129)
- Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach (2003) (128)
- Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer (2012) (124)
- Surgical treatment for gastric cancer: the Japanese approach. (1996) (121)
- Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections (2012) (117)
- Successful application of laparoscopic and endoscopic cooperative surgery (LECS) for a lateral-spreading mucosal gastric cancer (2012) (114)
- Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma (2001) (114)
- Cancer of the gastric stump following distal gastrectomy for cancer (2007) (114)
- Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF. (2002) (109)
- Symptom evaluation of long-term postoperative outcomes after pylorus-preserving gastrectomy for early gastric cancer (2007) (109)
- Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification (2010) (108)
- Evaluation of the new international union against cancer TNM staging for gastric carcinoma (2000) (107)
- Clinicopathological features of gastric cancer in young patients (2016) (106)
- Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study. (2019) (105)
- Prognostic Significance of Complications after Curative Surgery for Gastric Cancer (2014) (101)
- The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? (2001) (99)
- A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A) (2017) (98)
- Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years (2007) (97)
- Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery? (1999) (97)
- Phase II study of preoperative chemotherapy with S‐1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210) (2013) (96)
- Ten‐year follow‐up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia (2015) (96)
- Outcome of pylorus‐preserving gastrectomy for early gastric cancer (2008) (93)
- A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002 (2017) (88)
- Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples (2008) (87)
- The outcome of surgical treatment for gastric carcinoma in the elderly. (1998) (87)
- Metastatic bone cancer as a recurrence of early gastric cancer -- characteristics and possible mechanisms. (2005) (87)
- Recurrence in early gastric cancer with lymph node metastasis (2008) (85)
- Clinical Outcomes and Evaluation of Laparoscopic Proximal Gastrectomy with Double-Flap Technique for Early Gastric Cancer in the Upper Third of the Stomach (2017) (85)
- Large-scale investigation into dumping syndrome after gastrectomy for gastric cancer. (2010) (84)
- Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction (2013) (79)
- Follow-up of gastric cancer: a review (2006) (78)
- Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients (2013) (77)
- Postoperative Outcomes and Complications After Laparoscopy-assisted Pylorus-preserving Gastrectomy for Early Gastric Cancer (2011) (74)
- Gastric cancer surgery in the elderly without operative mortality. (2004) (71)
- Decreasing complication rates with stapled esophagojejunostomy following a learning curve (2000) (70)
- Early gastric stump cancer following distal gastrectomy. (1995) (69)
- Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002) (2009) (67)
- Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A) (2014) (66)
- THERAPEUTIC OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF UNDIFFERENTIATED‐TYPE INTRAMUCOSAL GASTRIC CANCER WITHOUT ULCERATION AND PREOPERATIVELY DIAGNOSED AS 20 MILLIMETRES OR LESS IN DIAMETER (2010) (65)
- Early Gastric Cancer: Diagnosis and Less Invasive Treatments (2006) (65)
- Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501) (2019) (63)
- Surgical Treatment of Advanced Gastric Cancer: Japanese Perspective (2007) (62)
- Gallstone Formation after Gastric Cancer Surgery (2009) (62)
- Postoperative Pancreatic Fistula and the Risk Factors of Laparoscopy-Assisted Distal Gastrectomy for Early Gastric Cancer (2011) (60)
- Laparoscopic-endoscopic cooperative surgery for duodenal tumors: a unique procedure that helps ensure the safety of endoscopic submucosal dissection (2014) (58)
- Treatment of early gastric cancer in the elderly patient: results of EMR and gastrectomy at a national referral center in Japan. (2005) (58)
- Extranodal metastasis is an indicator of poor prognosis in patients with gastric carcinoma (2006) (58)
- Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial. (2019) (56)
- Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer (2021) (55)
- Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer (2011) (54)
- Three-Step Esophagojejunal Anastomosis with Atraumatic Anvil Insertion Technique After Laparoscopic Total Gastrectomy (2011) (54)
- Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer (2018) (54)
- Should systematic lymph node dissection be recommended for gastric cancer? (1998) (53)
- Optimal Management of Gastric Cancer: Results From an International RAND/UCLA Expert Panel (2014) (52)
- Significance of the Inflammation-Based Glasgow Prognostic Score for Short- and Long-Term Outcomes After Curative Resection of Gastric Cancer (2012) (51)
- Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction (2013) (51)
- Mode of Recurrence after Gastric Cancer Surgery (1994) (50)
- Long‐term results of gastrectomy for α‐fetoprotein‐producing gastric cancer (2010) (49)
- Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery? (2015) (49)
- Amylase concentration of drainage fluid after total gastrectomy (1997) (49)
- Feasibility and Nutritional Impact of Laparoscopy-assisted Subtotal Gastrectomy for Early Gastric Cancer in the Upper Stomach (2014) (48)
- Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101) (2015) (48)
- Early gastric cancer: concepts, diagnosis, and management (2005) (47)
- Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference (2015) (47)
- Risk factors for pancreas-related abscess after total gastrectomy (2005) (47)
- Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. (2013) (45)
- Different Features of Complications with Billroth-I and Roux-en-Y Reconstruction After Laparoscopy-Assisted Distal Gastrectomy (2011) (45)
- Long-term and surgical outcomes of laparoscopic surgery for gastric gastrointestinal stromal tumors (2014) (44)
- Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer (2014) (44)
- Investigation of the Lymphatic Stream of the Stomach in Gastric Cancer with Solitary Lymph Node Metastasis (2009) (43)
- TNM and Japanese staging systems for gastric cancer: how do they coexist? (2004) (43)
- Chronic pain and quality of life following open inguinal hernia repair. (2002) (43)
- Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial (2020) (43)
- Survival benefit of pylorus-preserving gastrectomy in early gastric cancer. (2009) (42)
- Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence (2020) (42)
- Management of complications after gastrectomy with extended lymphadenectomy. (2000) (42)
- Laparoscopy-assisted subtotal gastrectomy with very small remnant stomach: a novel surgical procedure for selected early gastric cancer in the upper stomach (2011) (42)
- Significance of Lavage Cytology in Advanced Gastric Cancer Patients (2010) (41)
- Therapeutic Value of Lymph Node Dissection in Advanced Gastric Cancer with Macroscopic Duodenum Invasion: Is the Posterior Pancreatic Head Lymph Node Dissection Beneficial? (2009) (41)
- Long-term outcome and survival with laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer (2011) (41)
- Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications (2018) (40)
- Clinicopathological Characteristics and Survival Difference Between Gastric Stump Carcinoma and Primary Upper Third Gastric Cancer (2013) (40)
- Stage migration caused by D2 dissection with para‐aortic lymphadenectomy for gastric cancer from the results of a prospective randomized controlled trial (2006) (40)
- Gastric lymphography and detection of sentinel nodes. (2000) (40)
- The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging (2017) (39)
- Tailoring treatments for curable gastric cancer (2007) (39)
- Effects of reconstruction methods on a patient’s quality of life after a proximal gastrectomy: subjective symptoms evaluation using questionnaire survey (2009) (39)
- Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel. (2014) (38)
- Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer: Japan Clinical Oncology Group study (JCOG0501). (2018) (37)
- Diagnostic staging laparoscopy in gastric cancer: a prospective cohort at a cancer institute in Japan (2017) (36)
- A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study). (2015) (36)
- Clinical Impact of Abdominal Fat Distribution on Prognosis After Esophagectomy for Esophageal Squamous Cell Carcinoma (2016) (35)
- Role of Prealbumin as a Powerful and Simple Index for Predicting Postoperative Complications After Gastric Cancer Surgery (2017) (35)
- Feasibility of laparoscopic and endoscopic cooperative surgery for gastric submucosal tumors (with video). (2016) (35)
- Totally laparoscopic pylorus-preserving gastrectomy for early gastric cancer in the middle stomach: technical report and surgical outcomes (2014) (34)
- Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus (2014) (34)
- Surgical outcomes and risk assessment for anastomotic complications after laparoscopic proximal gastrectomy with double-flap technique for upper-third gastric cancer (2019) (33)
- The Clinical Safety of Performing Laparoscopic Gastrectomy for Gastric Cancer by Trainees after Sufficient Experience in Assisting (2013) (33)
- Use of endoscopy to determine the resection margin during laparoscopic gastrectomy for cancer (2017) (33)
- Modern Surgery for Gastric Cancer — Japanese Perspective (2006) (31)
- “Pancreas-Compressionless Gastrectomy”: A Novel Laparoscopic Approach for Suprapancreatic Lymph Node Dissection (2017) (31)
- One thousand consecutive gastrectomies without operative mortality. (2002) (31)
- Increased Fat Content and Body Shape Have Little Effect on the Accuracy of Lymph Node Retrieval and Blood Loss in Laparoscopic Distal Gastrectomy for Gastric Cancer (2009) (30)
- Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients (2018) (30)
- General perioperative management of gastric cancer patients at high-volume centers (2011) (30)
- Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood (2007) (30)
- Total gastrectomy for primary gastric lymphoma at stages IE and IIE: a prospective study of fifty cases. (1997) (30)
- Oncologic Outcomes of Laparoscopy-Assisted Distal Gastrectomy for Gastric Cancer (2013) (30)
- Pancreaticoduodenectomy for advanced gastric cancer (2004) (29)
- A randomized phase III study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer (JACCRO GC-07 trial). (2018) (29)
- The management of early gastric cancer. (2000) (28)
- Risk factors for para-aortic lymph node metastasis of gastric cancer from a randomized controlled trial of JCOG9501. (2007) (27)
- Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia (2007) (27)
- Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A) (2015) (27)
- Impact of human epidermal growth factor receptor (EGFR) and ERBB2 (HER2) expressions on survival in patients with stage II/III gastric cancer, enrolled in the ACTS-GC study. (2011) (27)
- Gastric carcinoma in young adults. (1996) (27)
- A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval. (1996) (27)
- Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma (JCOG0110): Analyzes of operative morbidity, operation time, and blood loss. (2010) (25)
- Increasing body mass index in Japanese patients with gastric cancer (2004) (25)
- Does the Single-Stapling Technique for Circular-Stapled Esophagojejunostomy Reduce Anastomotic Complications After Laparoscopic Total Gastrectomy? (2015) (25)
- Functional outcomes after extended surgery for gastric cancer (2011) (24)
- Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer (2014) (24)
- Oncological feasibility of laparoscopic subtotal gastrectomy compared with laparoscopic proximal or total gastrectomy for cT1N0M0 gastric cancer in the upper gastric body (2019) (24)
- The Hit and Away technique: optimal usage of the ultrasonic scalpel in laparoscopic gastrectomy (2015) (24)
- TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study (2017) (24)
- Node-positive mucosal gastric cancer: a follow-up study. (2001) (24)
- The concept of Tenju‐gann, or "natural‐end cancer" (1998) (23)
- Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy (2019) (23)
- An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis (2019) (23)
- Short-term Outcomes of Roux-en-Y Stapled Anastomosis after Distal Gastrectomy for Gastric Adenocarcinoma (2010) (22)
- Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002) (2019) (22)
- A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002. (2012) (22)
- [Evaluation of the gastric cancer treatment guidelines of the Japanese Gastric Cancer Association]. (2010) (22)
- Radical lymphadenctomy in the management of early gastric cancer (1997) (22)
- Pancreatic Compression during Lymph Node Dissection in Laparoscopic Gastrectomy: Possible Cause of Pancreatic Leakage (2018) (22)
- Esophagectomy for superficial esophageal cancer after non-curative endoscopic resection (2015) (22)
- TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study. (2017) (21)
- Impact of anatomical position of the pancreas on postoperative complications and drain amylase concentrations after laparoscopic distal gastrectomy for gastric cancer (2018) (21)
- Preserving infrapyloric vein reduces postoperative gastric stasis after laparoscopic pylorus-preserving gastrectomy (2017) (21)
- Improvement in short-term outcomes after esophagectomy with a multidisciplinary perioperative care team (2016) (21)
- Feasibility of further expansion of the indications for endoscopic submucosal dissection in undifferentiated-type early gastric cancer (2019) (20)
- 2221 Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer; short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG 0501) (2015) (19)
- Outcome of surgical treatment for patients with locoregional recurrence of gastric cancer (2011) (19)
- Laparoscopy‐assisted gastrectomy in patients with previous endoscopic resection for early gastric cancer (2011) (19)
- Correlation between the length of the pyloric cuff and postoperative evaluation after pylorus-preserving gastrectomy (2010) (19)
- A Prospective Randomized Trial Comparing a Combined Regimen of Amikacin and Levofloxacin to Levofloxacin Alone as Prophylaxis in Transrectal Prostate Needle Biopsy. (2016) (18)
- The Prognostic Impact of Isolated Tumor Cells in Lymph Nodes of T2N0 Gastric Cancer: Comparison of American and Japanese Gastric Cancer Patients (2009) (18)
- Potentially fatal complications for elderly patients after laparoscopy-assisted distal gastrectomy (2014) (18)
- Superior Thoracic Aperture Size is Significantly Associated with Cervical Anastomotic Leakage After Esophagectomy (2017) (18)
- Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma (JCOG0110): Final survival analysis. (2015) (18)
- A phase II study of preoperative chemotherapy (CX) with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancer: JCOG 0210 (2007) (18)
- A novel method of intracorporeal end-to-end gastrogastrostomy in laparoscopic pylorus-preserving gastrectomy for early gastric cancer, including a unique anastomotic technique: piercing the stomach with a linear stapler (2018) (18)
- Prospective feasibility study for single-tracer sentinel node mapping by ICG (indocyanine green) fluorescence and OSNA (one-step nucleic acid amplification) assay in laparoscopic gastric cancer surgery (2019) (18)
- Excellent Long-Term Prognosis and Favorable Postoperative Nutritional Status After Laparoscopic Pylorus-Preserving Gastrectomy (2017) (17)
- Surgical treatment for gastric leiomyosarcoma. (1998) (17)
- Adjuvant and neoadjuvant therapy of gastric cancer: A comparison of three pivotal studies (2008) (17)
- Two-point measurement of amylase in drainage fluid predicts severe postoperative pancreatic fistula after gastric cancer surgery (2018) (17)
- Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer (2016) (17)
- Radical lymphadenectomy in the management of early gastric cancer. (1997) (16)
- Primary results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001). (2017) (16)
- ALDH1A3‐mTOR axis as a therapeutic target for anticancer drug‐tolerant persister cells in gastric cancer (2020) (16)
- Randomized phase III trial of standard D2 versus D2 + para-aortic lymph node (PAN) dissection (D) for clinically M0 advanced gastric cancer: JCOG9501. (2006) (16)
- Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy (2019) (16)
- Preservation of the celiac branch of the vagal nerve for pylorus-preserving gastrectomy: is it meaningful? (2018) (15)
- Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07 (2021) (15)
- Lymphadenectomy and pancreatico-splenectomy in gastric cancer surgery (1996) (15)
- Factors influencing difficulty of the thoracic procedure in minimally invasive esophagectomy (2016) (15)
- Long-term results of hepatic resection for non-colorectal, non-neuroendocrine liver metastasis. (2013) (15)
- Anatomic site‐specific proteomic signatures of gastrointestinal stromal tumors (2009) (15)
- Current status of perioperative chemotherapy for locally advanced gastric cancer and JCOG perspectives. (2020) (15)
- Phase III trial to evaluate the efficacy of neoadjuvant chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with adjuvant S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA trial). (2017) (15)
- Survival benefit of “D2-plus” gastrectomy in gastric cancer patients with duodenal invasion (2018) (15)
- A phase II study of preoperative chemotherapy with S-1 (S) and cisplatin (P) followed by D3 gastrectomy for gastric cancer (GC) with extensive lymph node metastasis (ELM): Survival results of JCOG0405. (2011) (15)
- Primary large cell neuroendocrine carcinoma of the urinary bladder (2008) (14)
- Thoracic Lymph Node Involvement in Adenocarcinoma of the Esophagogastric Junction and Lower Esophageal Squamous Cell Carcinoma Relative to the Location of the Proximal End of the Tumor (2014) (14)
- Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study (2020) (14)
- A Phase III trial to evaluate the effect of perioperative nutrition enriched with eicosapentaenoic acid on body weight loss after total gastrectomy for T2-T4a gastric cancer. (2012) (14)
- Wedge resection of the stomach for gastric leiomyosarcoma (1997) (14)
- Feasibility of Gastrectomy with Standard Lymphadenectomy for Patients Over 85 Years Old with Gastric Cancer (2015) (14)
- Distribution of the deepest penetrating point of minute submucosal gastric cancer. (2005) (14)
- Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013). (2018) (14)
- The macroscopic diagnosis of lymph node metastasis from early gastric cancer (2005) (13)
- Characteristics of gastric stump cancer: A single hospital retrospective analysis of 262 patients. (2016) (13)
- Incidence of nodal metastasis around the superior border of the pancreas based on number of metastatic perigastric nodes (1998) (13)
- Rituximab alone was effective for the treatment of a diffuse large B-cell lymphoma associated with hemophagocytic syndrome (2007) (13)
- Gastric Adenocarcinoma of Fundic Gland Type with Aggressive Transformation and Lymph Node Metastasis: a Case Report (2018) (13)
- Duodenal stump reinforcement might reduce both incidence and severity of duodenal stump leakage after laparoscopic gastrectomy with Roux-en-Y reconstruction for gastric cancer (2019) (12)
- Laparoscopic proximal gastrectomy with double‐flap technique versus laparoscopic subtotal gastrectomy for proximal early gastric cancer (2019) (12)
- What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel. (2013) (12)
- Clinical Significance of Molecular Detection of Matrix metalloproteinase-1 in Bone Marrow and Peripheral Blood in Patients with Gastric Cancer (2012) (12)
- Laparoscopic subtotal gastrectomy with a new marking technique, endoscopic cautery marking: preservation of the stomach in patients with upper early gastric cancer (2018) (12)
- Efficacy of Staged Treatment Strategy for Patients with Synchronous Double Cancers of the Esophagus and Head and Neck: A Retrospective Study (2016) (11)
- Institutional variation in short- and long-term outcomes after surgery for gastric or esophagogastric junction adenocarcinoma: correlative study of two randomized phase III trials (JCOG9501 and JCOG9502) (2017) (11)
- Subtotal Gastrectomy with Limited Lymph Node Dissection is a Feasible Treatment Option for Patients with Early Gastric Stump Cancer (2014) (11)
- A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II. (1997) (11)
- Updates on Surgical Management of Advanced Gastric Cancer: New Evidence and Trends. Insights from the First International Course on Upper Gastrointestinal Surgery—Varese (Italy), December 2, 2011 (2013) (11)
- Randomized phase III study of etoposide plus cisplatin versus irinotecan plus cisplatin in advanced neuroendocrine carcinoma of the digestive system: A Japan Clinical Oncology Group study (JCOG1213). (2015) (10)
- In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells (2019) (10)
- Early gastric stump cancer following distal gastrectomy (1998) (10)
- Green tea and gastric cancer. (2001) (10)
- [Investigation of meropenem levels in the human bone marrow blood, bone, joint fluid and joint tissues]. (1993) (10)
- Is proximal gastrectomy indicated for locally advanced cancer in the upper third of the stomach? (2021) (9)
- Risk factors and prognosis of gastric stasis, a crucial problem after laparoscopic pylorus-preserving gastrectomy for early middle-third gastric cancer (2020) (9)
- Prognostic factors for survival in patients with pT1 N+ or T2–3 N0 gastric cancer in Japan (2017) (9)
- Result of HER2 status in Japanese metastatic gastric cancer: Prospective cohort study (JFMC44-1101). (2013) (9)
- Postoperative Prolonged Inflammatory Response as a Poor Prognostic Factor After Curative Resection for Gastric Cancer (2017) (9)
- Treatment of primary gastric lymphoma: experience in the National Cancer Center Hospital, Tokyo. (2000) (8)
- [Reconstruction after distal gastrectomy]. (2008) (8)
- Therapeutic value of splenectomy to dissect splenic hilar lymph nodes for type 4 gastric cancer involving the greater curvature, compared with other types (2020) (8)
- Unplanned admission after gastrectomy as a consequence of fast-track surgery: a comparative risk analysis (2016) (8)
- TREATMENT RESULTS OF GASTRIC CANCER PATIENTS : AN ANALYSIS OF NATIONWIDE DATABASE (1995) (7)
- 626PDA randomized phase III trial comparing 4 courses and 8 courses of S-1 adjuvant chemotherapy for p-stage II gastric cancer: JCOG1104 (OPAS-1) (2017) (7)
- Revised points and disputed matters in the eighth edition of the TNM staging system for gastric cancer. (2021) (7)
- Left thoraco-abdominal approach (LT) compared with abdominal and transhiatal approach (AT) for cardia or sub-cardia cancer. Results of a surgical randomized controlled trial (JCOG9502). (2004) (7)
- Two cases of a perforated duodenal diverticulum after gastrectomy with Roux-en-Y reconstruction (2019) (7)
- Comparison of synchronous versus staged surgeries for patients with synchronous double cancers of the esophagus and head-and-neck. (2016) (7)
- [Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer]. (1994) (7)
- Meeting report of the 72nd Japanese Gastric Cancer Congress (2000) (6)
- [Adjuvant chemotherapy using S-1 for curatively resected gastric cancer-the nationwide clinical trial]. (2006) (6)
- A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer (JCOG0912): Analysis of the safety and short-term clinical outcomes. (2015) (6)
- Should pylorus-preserving gastrectomy be performed for overweight/obese patients with gastric cancer? (2019) (6)
- Clinical Significance of the Pre-therapeutic Nodal Size in Patients Undergoing Neo-Adjuvant Treatment Followed by Esophagectomy for Esophageal Squamous Cell Carcinoma (2016) (6)
- Meeting report: The 75th Congress of the Japanese Gastric Cancer Association (2004) (6)
- Randomized Controlled Trials on Adjuvant Therapy for Gastric Cancer: Japanese Experience (1999) (6)
- A phase III trial to confirm modified S-1 adjuvant chemotherapy for pathological stage II/III vulnerable elderly gastric cancer patients who underwent gastric resection (JCOG1507, BIRDIE). (2018) (6)
- Postoperative complications after a transthoracic esophagectomy or a transhiatal gastrectomy in patients with esophagogastric junctional cancers: a prospective nationwide multicenter study (2021) (6)
- [Surgical indication and survival benefit of hepatectomy for gastric cancer liver metastasis]. (2012) (5)
- Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy. (2021) (5)
- FBXW7 loss of function contributes to worse overall survival and is associated with accumulation of MYC in muscle invasive bladder cancer (2020) (5)
- Diagnosis of invasion depth in resectable advanced gastric cancer for neoadjuvant chemotherapy: An exploratory analysis of Japan clinical oncology group study: JCOG1302A. (2020) (5)
- The prognostic significance of tumor laterality in patients with esophageal squamous cell carcinoma (2012) (5)
- A “Just Enough” Gross Proximal Margin Length Ensuring Pathologically Complete Resection in Distal Gastrectomy for Gastric Cancer (2020) (5)
- Survival outcomes of elderly patients with pathological stages II and III gastric cancer following curative gastrectomy (2020) (5)
- Size-dependent differences in the proximal remnant stomach: how much does a small remnant stomach after subtotal gastrectomy work? (2020) (5)
- Perirenal fat thickness as a predictor of postoperative complications after laparoscopic distal gastrectomy for gastric cancer (2020) (5)
- Is laparoscopic and endoscopic cooperative surgery (LECS) for gastric subepithelial tumor at the esophagogastric junction safe? (2020) (5)
- Anti‐Hu‐antibody‐associated paraneoplastic neurological syndrome accompanying testicular cancer (2010) (5)
- Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center (2018) (5)
- Update on Surgery of Gastric Cancer: New Procedures versus Standard Technique (2005) (5)
- Effectiveness and limitations of staging laparoscopy for peritoneal metastases in advanced gastric cancer from the results of JCOG0501: A randomized trial of gastrectomy with or without neoadjuvant chemotherapy for type 4 or large type 3 gastric cancer. (2017) (4)
- We have entered a new era of adjuvant/neoadjuvant therapy for gastric cancer. (2007) (4)
- An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer (GC) with extensive lymph node metastasis (ELM). (2011) (4)
- Short- and long-term oncological outcomes of totally laparoscopic gastrectomy versus laparoscopy-assisted gastrectomy for clinical stage I gastric cancer (2021) (4)
- Report of the Seventeenth International Symposium of the Foundation for Promotion of Cancer Research: Recent Advances in Gastric Cancer. (2004) (4)
- Oncological Impact of Gross Proximal Margin Length in Distal Gastrectomy for Gastric Cancer: Is the Japanese Recommendation Valid? (2021) (4)
- A RAND/UCLA Appropriateness Study of the Management of Familial Gastric Cancer (2013) (4)
- Metastasis to the lymph nodes along the proper hepatic artery from adenocarcinoma of the stomach (2016) (4)
- Laparoscopic pancreatoduodenectomy combined with a novel self-assessment system and feedback discussion: a phase 1 surgical trial following the IDEAL guidelines (2016) (4)
- Morphological alterations of glomerulus induced by infusion of cationized ferritin (1993) (4)
- Correction to: Clinical Outcomes and Evaluation of Laparoscopic Proximal Gastrectomy with Double-Flap Technique for Early Gastric Cancer in the Upper Third of the Stomach (2018) (4)
- Preoperative vs Postoperative Eradication of Helicobacter pylori in 150 Patients with Gastric Cancer: A Randomized Controlled Trial. (2015) (4)
- Shorter Survival of Patients with Upper-Third Gastric Cancer Preoperatively Diagnosed as Stage IA Compared with Those with Middle to Lower Lesions (2019) (4)
- [TNM classification: cancer of the stomach]. (1998) (4)
- Preliminary prospective study of real-time post-gastrectomy glycemic fluctuations during dumping symptoms using continuous glucose monitoring (2021) (3)
- [Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer]. (2000) (3)
- Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists (2020) (3)
- Circulating tumor DNA in patients with metastatic urothelial cancer: concordance of genomic findings with matched tissue biopsies. (2019) (3)
- Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101) (2015) (3)
- Risk factors and oncological impact of positive resection margins in gastrectomy for cancer: are they salvaged by an additional resection? (2021) (3)
- Erratum to: Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer (2014) (3)
- Interaction between intratumoral ERCC1 expression and adjuvant treatment with S-1 on the survival of patients enrolled in the ACTS-GC study. (2012) (3)
- Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for advanced gastric cancer: exploratory analysis of the JCOG1001 phase III trial (2021) (3)
- Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for advanced gastric cancer: exploratory analysis of the JCOG1001 phase III trial (2021) (3)
- Advantageous Short-Term Outcomes of Esophagojejunostomy Using a Linear Stapler Following Open Total Gastrectomy Compared with a Circular Stapler (2021) (3)
- Postprandial Asymptomatic Glycemic Fluctuations after Gastrectomy for Gastric Cancer Using Continuous Glucose Monitoring Device (2021) (3)
- Intussusception causing postoperative intestinal obstruction following free jejunum transfer in adults: two case reports and review of the literature (2015) (3)
- Concordance of HER2 and its related molecules between primary and paired liver metastatic sites in gastric cancer. (2013) (3)
- Immunoblastic lymphadenopathy in a five-month-old girl: successful treatment with immunosuppressants. (1994) (3)
- Subgroup analysis of JCOG0501 phase III study to confirm superiority of additional neoadjuvant chemotherapy with S-1 plus cisplatin to D2 gastrectomy with S-1 adjuvant chemotherapy for resectable type IV or large type III gastric cancer. (2019) (3)
- Impact of the gene expressions of thymidylate synthase and dihydropyrimidine dehydrogenase on survival in patients enrolled in the ACTS-GC study. (2012) (3)
- Immunogenic characteristics of microsatellite instability‐low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses (2020) (3)
- Antiperistaltic Jejunal Intussusception into the Roux-en-Y Anastomotic Site after Distal Gastrectomy (2014) (3)
- Detection and HER2 expression of circulating tumor cells in advanced gastric cancer patients. (2012) (2)
- Risk factors for the continuation of S-1 adjuvant chemotherapy for gastric cancer analyzed from the JCOG1104 phase III trial. (2021) (2)
- Pre-planned feasibility and safety analyses of docetaxel/S-1 combination in a phase III study comparing docetaxel/S-1with S-1 alone as postoperative adjuvant chemotherapy for stage III gastric cancer (JACCRO GC-07). (2015) (2)
- Computer Assisted Surgery for Gastric Cancer (1993) (2)
- Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study (2021) (2)
- Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A (2020) (2)
- Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer (2020) (2)
- Features of the complications for intracorporeal Billroth-I and Roux-en-Y reconstruction after laparoscopic distal gastrectomy for gastric cancer (2021) (2)
- Effect of Experimental Hypochlorhydria on the Histological Differentiation of Adenocarcinomas in the Canine Stomach (1993) (2)
- Early gastric caner (1990) (2)
- A randomized phase II trial of systemic chemotherapy with or without trastuzumab followed by surgery in HER2 positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger study). (2016) (2)
- Increased Rate of Serum Prealbumin Level after Preoperative Enteral Nutrition as an Indicator of Morbidity in Gastrectomy for Gastric Cancer with Outlet Obstruction (2022) (2)
- Risk Factors for Para-Aortic Lymph Node Metastasis in Esophagogastric Junction Cancer: Results from a Prospective Nationwide Multicenter Study (2022) (2)
- Confirmed three-year RFS and OS of the randomized trial of adjuvant S-1 versus S-1 plus docetaxel after curative resection of pStage III gastric cancer (JACCRO GC-07). (2021) (2)
- Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence (2020) (1)
- Minimum Esophageal Resection Length to Ensure Negative Proximal Margin in Total Gastrectomy for Gastric Cancer (2022) (1)
- A phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by gastrectomy with D2 plus para-aortic lymph node (PAN) dissection for gastric cancer with extensive lymph node metastasis (ELM): Japan Clinical Oncology Group Study JCOG1002. (2015) (1)
- A QUESTIONNAIRE SURVEY ON CANDIDATES FOR PALLIATIVE GASTRIC RESECTION FOR NON -CURATIVE GASTRIC CANCER (2005) (1)
- [Differences between Japan and the west in treatment strategy for gastrointestinal cancer--gastric cancer]. (1998) (1)
- Intraoperative conversion from laparoscopic gastrectomy to an open procedure: a decade of experience in a Japanese high-volume center (2020) (1)
- Genomic concordance between profiling of circulating tumor DNA (ctDNA) and matched tissue in metastatic urothelial carcinoma. (2019) (1)
- Reflux Esophagitis After Laparoscopic Pylorus-Preserving Gastrectomy for Gastric Cancer (2022) (1)
- Pancreatic atrophy after gastrectomy for gastric cancer (2020) (1)
- FA04.02: JAPANESE MULTICENTER PROSPECTIVE STUDY FOR ESOPHAGOGASTRIC JUNCTION CANCER (2018) (1)
- Updated report of a randomized phase III trial comparing 4 and 8 courses of S-1 adjuvant chemotherapy for p-stage II gastric cancer: JCOG1104 (OPAS-1). (2018) (1)
- Impact of tumor-related factors and inter-institutional heterogeneity on preoperative T staging for gastric cancer. (2022) (1)
- Authors' reply: proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction (Br J Surg 2013; 100: 1050–1054) (2014) (1)
- Gastric Cancer (2019) (1)
- In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells (2019) (1)
- Favorable Outcomes of Neoadjuvant Chemotherapy and Limited Para-Aortic Lymph Node Dissection for Advanced Gastric Cancer with Para-aortic Lymph Node Metastasis (2021) (1)
- Determination of the optimal cutoff percentage of residual tumors to define the pathologic response rate (pathRR) of gastric cancer (GC) treated with preoperative therapy (JCOG1004-A). (2013) (1)
- High prevalence of peritoneal metastasis in gastric cancer presenting gastric outlet obstruction: A new candidate for consecutive diagnostic staging laparoscopy and laparoscopic gastrojejunostomy. (2022) (1)
- Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy (2022) (1)
- Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin (2023) (1)
- Prediction of the peritoneal recurrence via the macroscopic diagnosis of the serosal invasion in patients with gastric cancer: Supplementary analysis of JCOG0110. (2022) (1)
- [The current situation and treatment strategy for gastric cancer at the National Cancer Center of Tokyo, Japan]. (1994) (1)
- A case of pancreaticoduodenal artery aneurysm which ruptured into the duodenum after laparoscopic distal gastrectomy (2012) (1)
- An international forum for discussion of gastric cancer is needed, particularly now (2005) (1)
- Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer (2022) (1)
- Key Factors for Maintaining Postoperative Skeletal Muscle Mass After Laparoscopic Proximal Gastrectomy with Double-Flap Technique Reconstruction for Early Gastric Cancer (2020) (1)
- Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction (Br J Surg 2013; 100: 1050-1054). (2014) (1)
- A phase III trial to confirm the superiority of S-1 adjuvant chemotherapy for vulnerable elderly patients with pathological stage II/III gastric cancer after curative resection: JCOG1507 (BIRDIE). (2018) (1)
- Long-term outcome of preoperative docetaxel with cisplatin plus S-1 therapy for advanced gastric cancer with extensive nodal metastasis (JCOG1002). (2019) (1)
- Correction to: Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center (2018) (1)
- [Problems of international standardization of gastric cancer surgery]. (2001) (1)
- Two Cases of Gastric Adenocarcinomas after the Remission of Gastric Malignant Lymphoma treated by Chemo-Radiotherapy (2008) (1)
- Indications for local resection for gastric leiomyosarcoma (1995) (1)
- Diagnosis of invasion depth in resectable advanced gastric cancer for neoadjuvant chemotherapy: An exploratory analysis of JCOG1302A. (2018) (1)
- [Surgical treatment for gastric cancer in western countries]. (2001) (0)
- Endoscopic Surgery in the Field of Gastroenterology : Stomach and duodenum (2009) (0)
- Japanese gastric cancer treatment guidelines, 3rd edition (The 49th annual meeting of Japanese Society of Clinical Oncology educational book) -- (JSCO University: Upper gastrointestinal cancers) (2011) (0)
- IV-4-3 Laparoscopic total gastrectomy(Gastric surgery,International Video Teleconference) (2009) (0)
- A Case of Early Gastric Cancer with Extensive Lymph Node Metastases in which Tumor Invasion into the Submucosa Was Demonstrated only after Detailed Pathological Examination (2012) (0)
- Detection and HER2 Expression of Circulating Tumor Cells in Advanced Gastric Cancer Patients (2012) (0)
- Correction to: Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study (2021) (0)
- Association between intratumoral HER2 heterogeneity (IHH) and trastuzumab (T-mab) efficacy in HER2 positive–gastric cancer (GC). (2015) (0)
- Advantages of Function-Preserving Gastrectomy for Older Patients With Upper-Third Early Gastric Cancer: Maintenance of Nutritional Status and Favorable Survival (2023) (0)
- Vagus nerve-preserving distal gastrectomy may improve the quality of life after gastrectomy in early stage gastric cancer patients (2016) (0)
- Phase II trial of induction mFOLFOX6 plus bevacizumab followed by neoadjuvant S-1-based chemoradiation for MRI-defined poor-risk rectal cancer. (2016) (0)
- [Practice guidelines in western countries]. (1999) (0)
- Final results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001). (2021) (0)
- Immunological Investigation of the Blood of the Persons inoculated with Cholera Vaccine, Cholera Convalescent Cases and Cholera Carriers. (0)
- Required esophageal resection length beyond the tumor boundary to ensure a negative proximal margin for gastric cancer with gross esophageal invasion or esophagogastric junction cancer (2023) (0)
- ASO Visual Abstract: Risk Factors for Para-Aortic Lymph Node Metastasis in Esophagogastric Junction Cancer: Results from a Prospective Nationwide Multicenter Study (2022) (0)
- Correction to: Intraoperative conversion from laparoscopic gastrectomy to an open procedure: a decade of experience in a Japanese high‑volume center (2020) (0)
- Nishi Memorial Award in Gastric Cancer (2010) (0)
- Circulating tumour DNA (ctDNA) utility as a biomarker for metastatic urothelial carcinoma (mUC) (2019) (0)
- Survival results by the prospectively determined clinical staging for locally advanced gastric cancer: An ancillary study of JCOG1302A (JCOG1302A2). (2023) (0)
- Feasibility and pathological response of TAS-118 + oxaliplatin as perioperative chemotherapy for patients with locally advanced gastric cancer (APOLLO-11). (2020) (0)
- [International perspectives on the treatment of gastric cancer]. (1998) (0)
- SSY-2-1-1 Surgical treatments by stage, standard and in trial, in Japan (2004) (0)
- A Clinical Evaluation of Cepharanthin for the Treatment of Several Nasal Diseases (1964) (0)
- [Prevention of gastric stump carcinoma]. (2001) (0)
- A History of Gastric Cancer Surgery and the Evidence for it (2019) (0)
- Feasibility study of TAS-118 plus oxaliplatin as perioperative chemotherapy for patients with locally advanced gastric cancer (APOLLO-11). (2021) (0)
- EP1376: ANTIADHESION MEMBRANE IS NOT EFFECTIVE IN THE PREVENTION OF SMALL BOWEL OBSTRUCTION AFTER OPEN GASTRECTOMY FOR GASTRIC CANCER: A SUPPLEMENTAL ANALYSIS OF THE MULTICENTER RANDOMIZED CONTROLLED TRIAL JCOG1001 (2022) (0)
- Excellent oncological outcomes besides short-term safety of laparoscopic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumor (2022) (0)
- Surrogate indicators of survival in patients who received neoadjuvant chemotherapy for type 4 and large type 3 gastric cancer in JCOG0501. (2020) (0)
- Real value of restaging laparoscopy for gastric cancer after preoperative therapy (2019) (0)
- [Role of live demonstration in open abdominal surgery]. (2013) (0)
- Para-Aortic Lymphadenectomy for Gastric Cancer (2014) (0)
- Laparoscopic Right Lateral Pelvic Lymph Node Dissection (LPLND) with Pelvic Autonomic Nerve Preservation (2016) (0)
- PD-0003 Comparison of GD-EOB-DTPA Enhanced Mri and Contrast-Enhanced Intraoperative Ultrasound using Sonazoid in Patients Undergoing Liver Resection for Colorectal Liver Metastasis (2012) (0)
- [Proposal for revision of guideline for treatment of stomach cancer]. (2008) (0)
- A mouse model of bladder-specific over-expression of NOTCH2 confirms the oncogenic role of NOTCH2 in bladder cancer (2017) (0)
- Association of gene expressions of TOP2A, GGH, and PECAM1 with hematogenous, lymph-node, and peritoneal recurrence in patients with stage II/III gastric cancer enrolled in the ACTS-GC study. (2013) (0)
- Minimum resection length to ensure a pathologically negative distal margin and the preservation of a larger remnant stomach in proximal gastrectomy for early upper gastric cancer (2022) (0)
- Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort. (2023) (0)
- Oncological outcomes in patients with pT1N0–3 or pT2–3N0 gastric cancer after curative resection without adjuvant chemotherapy (2021) (0)
- MSI-low is an intermediate type between MSI-high and MSS in esophagogastric junction adenocarcinoma. (2019) (0)
- NOTCH2 IN THE BLADDER PROMOTES TUMOR DEVELOPMENT AND LEADS TO MORE MALIGNANT PHENOTYPE.: MP65‐05 (2018) (0)
- ASO Author Reflections: Severe Reflux Esophagitis After Laparoscopic Pylorus-Preserving Gastrectomy for Gastric Cancer is Associated with Male Sex, Preoperative Grade A Reflux Esophagitis, Postoperative BMI of ≥23 kg/m2, Hiatal Hernia, and Long-Term Gastric Stasis (2022) (0)
- 771TiPA feasibility study of TAS-118 plus oxaliplatin as perioperative chemotherapy for locally advanced gastric cancer (2017) (0)
- 1399P Risk factors for body weight loss after gastrectomy for gastric cancer analysed from the JCOG1001 phase III trial (2021) (0)
- Abstract PR08: The genomic landscape of metastatic urothelial carcinoma from circulating tumor DNA (2020) (0)
- Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study. (2023) (0)
- Survival analysis of linitis plastica advanced gastric cancer patients receiving S-1 plus cisplatin. (2013) (0)
- [Informed consent for surgical treatment of gastric cancer]. (2001) (0)
- Impact of insulin-like growth factor 1 receptor (IGF1R) and amphiregulin (AREG) expressions on survival in patients with stage II/III gastric cancer enrolled in the ACTS-GC study. (2012) (0)
- Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer (2021) (0)
- [An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy]. (1990) (0)
- P-01 Efficacy of staged treatment strategy for patients with synchronous double cancers of the esophagus and head and neck (2015) (0)
- Recurrence patterns after curative gastrectomy for pStage II/III gastric cancer: Exploratory analysis of the randomized controlled JCOG1001 trial. (2022) (0)
- A continuous muscle-sparing advantage of pylorus-preserving gastrectomy for older patients with cT1N0M0 gastric cancer in the middle third of the stomach (2022) (0)
- Risk factors for recurrence in each pattern after curative gastrectomy for pStage II/III gastric cancer: An exploratory analysis of a randomized controlled trial (JCOG1001). (2021) (0)
- Change in the Nutritional Status from the Time of the First Visit to the Day before Surgery in Gastric Cancer Patients (2017) (0)
- Post-recurrent survival of a phase III trial comparing adjuvant chemotherapy with docetaxel plus S-1 versus S-1 alone in stage III gastric cancer: A post-hoc analysis of the START-2 trial (JACCRO GC-07). (2023) (0)
- Anatomical Position of the Pancreas as a Risk Factor for Pancreatic Fistula after Laparoscopic Gastrectomy for Gastric Cancer. (2023) (0)
- ASO Visual Abstract: Reflux Esophagitis After Laparoscopic Pylorus-Preserving Gastrectomy for Gastric Cancer (2022) (0)
- [Advancements in endoscopic surgery for gastric and esophageal cancer]. (2010) (0)
- [Relationship between type of suture and anastomotic stricture after radical prostatectomy]. (2010) (0)
- 1444P Real-world nivolumab safety data from 650 patients with unresectable advanced or recurrent gastric cancer that had progressed after cancer chemotherapy: Summary of post-marketing surveillance in Japan (2020) (0)
- Guideline for clinical safety data management in Japan Clinical Oncology Group (JCOG) (version 4) (2001) (0)
- LINE-1 hypo-methylation as a distinct phenotype in non-EBV/non-MSI-H esophagogastric junction adenocarcinoma. (2020) (0)
- 205. A Study of the Connection between Krukenberg's Tumor and Gastric Cancer with Reference to the Role of the Lymph System (1982) (0)
- 26. A Clinical Pathology on the Gastric Cancer with Krokenberg's Tumor or Schnitzler Tumor, Especially its Metastatic Pathway (1981) (0)
- Successful open radical gastrectomy for locally advanced or metastatic gastric cancer patients who suffered from coronavirus disease 2019 during preoperative chemotherapy: a report of three cases (2022) (0)
- 1475P Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for cT3/4a gastric cancer - Exploratory analysis of JCOG1001 study (2020) (0)
- Endoscopic resection of undifferentiated-type gastric carcinoma: an extreme step to be restrained? (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Takeshi Sano?
Takeshi Sano is affiliated with the following schools:
